Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury

The outcome of coronavirus disease 2019 (COVID-19) is associated with organ damage; however, the information about the relationship between acute kidney injury (AKI) and COVID-19 is still rare. We evaluated the clinical features and prognosis of COVID-19 patients with AKI according to the AKI severi...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2020-06, Vol.9 (6), p.1718
Main Authors: Lim, Jeong-Hoon, Park, Sun-Hee, Jeon, Yena, Cho, Jang-Hee, Jung, Hee-Yeon, Choi, Ji-Young, Kim, Chan-Duck, Lee, Yong-Hoon, Seo, Hyewon, Lee, Jaehee, Kwon, Ki Tae, Kim, Shin-Woo, Chang, Hyun-Ha, Kim, Yong-Lim
Format: Article
Language:English
Subjects:
Clinical medicine
Coronaviruses
COVID-19
Fatalities
Middle East respiratory syndrome
Mortality
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The outcome of coronavirus disease 2019 (COVID-19) is associated with organ damage; however, the information about the relationship between acute kidney injury (AKI) and COVID-19 is still rare. We evaluated the clinical features and prognosis of COVID-19 patients with AKI according to the AKI severity. Medical data of hospitalized COVID-19 patients in two university-based hospitals during an outbreak in Daegu, South Korea, were retrospectively analyzed. AKI and its severity were defined according to the Acute Kidney Injury Network. Of the 164 hospitalized patients with COVID-19, 30 patients (18.3%) had AKI; 14, 4, and 12 patients had stage 1, 2, and 3, respectively. The median age was significantly higher in AKI patients than in non-AKI patients (75.5 vs. 67.0 years, p = 0.005). There were 17 deaths (56.7%) among AKI patients; 4 (28.6%), 1 (25.0%), and 12 (100.0%), respectively. In-hospital mortality was higher in AKI patients than in non-AKI patients (56.7% vs. 20.8%, p < 0.001). After adjusting for potential confounding factors, stage 3 AKI was associated with higher mortality than either non-AKI or stage 1 AKI (hazard ratio (HR) = 3.62 (95% confidence interval (CI) = 1.75–7.48), p = 0.001; HR = 15.65 (95% CI = 2.43–100.64), p = 0.004). Among the AKI patients, acute respiratory distress syndrome and low serum albumin on admission were considered independent risk factors for stage 3 AKI (both p < 0.05). Five patients with stage 3 AKI underwent dialysis and eventually died. In conclusion, COVID-19 patients with severe AKI had fatal outcomes.
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm9061718